乌罗莫杜林在心血管疾病中的作用:一篇综述
Chengqian Chen1, Wentao Zhong2, Hao Zheng2
1Department of Cardiology Center, The First Hospital of Jilin University, Changchun, China.
Frontiers in cardiovascular medicine
|July 25, 2024
概括
尿素是一种产生的蛋白质,与心血管事件有关. 本综述探讨了它作为预测心血管疾病和死亡率的新生物标志物的作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 生物标志物发现发现
背景情况:
- 尿模蛋白 (Tamm Horsfall蛋白) 是主要的尿蛋白,仅在脏中合成.
- 它在功能中起着关键作用,包括离子运输,免疫调节和预防尿路感染和结石.
- 最近的研究表明,除了脏健康之外,uromodulin作为生物标志物的潜力,与心血管事件有关.
研究的目的:
- 审查乌罗摩杜林与心血管疾病 (CVD) 之间的关系.
- 阐明uromodulin作为心血管事件的新生物标志物的预测效用.
- 探索uromodulin在心血管系统中的生理和病理生理作用.
主要方法:
- 临床研究和门德尔随机化研究的文献综述.
- 对乌罗莫杜林与心血管结果相关的新兴证据的分析.
- 纳入与乌罗莫杜林和心血管疾病相关的近期遗传进展.
主要成果:
- 尿液中的泌尿尿素水平与心血管事件和死亡率有明显的关联.
- 乌罗莫杜林显示出作为心血管风险预测生物标志物的潜力.
- 有证据表明,uromodulin参与各种心血管生理和病理生理过程.
结论:
- 乌罗摩杜林是一种有前途的新型心血管疾病生物标志物.
- 对乌罗莫杜林心血管作用的进一步研究是有必要的.
- 了解uromodulin的遗传学可能会为预防和治疗心血管疾病提供新的见解.
更多相关视频
10:28Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
9.3K
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
9.8K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
01:22Heart Failure Drugs: Diuretics
356
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
356
01:23Antihypertensive Drugs: Vasodilators
495
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
495
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
01:17Hormonal Regulation of Blood Pressure
2.5K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.5K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K